New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

Updated on: January 11,2024

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

Updated on:January 11,2024

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on: December 25,2023

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on:December 25,2023

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainImaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather tha

Updated on: May 06,2024

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainImaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather tha

Updated on:May 06,2024

Fibroblasts involved in healing spur tumor growth in cancer

byTel Aviv UniversityCredit: Tel Aviv UniversityThe connective tissue cells known as fibroblasts are vitally important for our recovery from injury. Sensing tissue damage, they gravitate to the

Updated on: December 22,2023

Fibroblasts involved in healing spur tumor growth in cancer

byTel Aviv UniversityCredit: Tel Aviv UniversityThe connective tissue cells known as fibroblasts are vitally important for our recovery from injury. Sensing tissue damage, they gravitate to the

Updated on:December 22,2023

Precision physical activity prescriptions improve survival in colon cancer

by Pennington Biomedical Research CenterCredit: Unsplash/CC0 Public DomainPhysical activity may be associated with improved outcomes for patients undergoing postoperative treatment for Stage III colon

Updated on: December 26,2023

Precision physical activity prescriptions improve survival in colon cancer

by Pennington Biomedical Research CenterCredit: Unsplash/CC0 Public DomainPhysical activity may be associated with improved outcomes for patients undergoing postoperative treatment for Stage III colon

Updated on:December 26,2023

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on: November 10,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on:November 10,2024

Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have formulated a tuneable, nanoengineered bioink for tumor modeling which contai

Updated on: January 04,2024

Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have formulated a tuneable, nanoengineered bioink for tumor modeling which contai

Updated on:January 04,2024

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on: January 11,2024

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on:January 11,2024

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Updated on: June 28,2024

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Updated on:June 28,2024

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in

Updated on: March 24,2024

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in

Updated on:March 24,2024

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on: July 17,2024

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on:July 17,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on: January 26,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on:January 26,2024